CVS Health (NYSE:CVS) Raised to Buy at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health (NYSE:CVS) from a hold rating to a buy rating in a research note published on Tuesday, MarketBeat Ratings reports. They currently have $66.00 target price on the pharmacy operator’s stock.

CVS has been the subject of a number of other reports. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. Mizuho reduced their target price on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. Royal Bank of Canada reduced their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a report on Friday, November 15th. Evercore ISI upped their target price on shares of CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. Finally, TD Cowen upped their target price on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a report on Monday, November 25th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $70.50.

CVS Health Stock Up 0.2 %

CVS opened at $59.20 on Tuesday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The firm has a 50 day moving average price of $59.43 and a 200-day moving average price of $58.80. CVS Health has a twelve month low of $52.71 and a twelve month high of $83.25. The stock has a market capitalization of $74.50 billion, a price-to-earnings ratio of 15.03, a PEG ratio of 1.01 and a beta of 0.54.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. During the same period in the previous year, the company earned $2.21 earnings per share. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. Equities research analysts forecast that CVS Health will post 5.37 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were given a dividend of $0.665 per share. The ex-dividend date was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.49%. CVS Health’s dividend payout ratio is 67.51%.

Hedge Funds Weigh In On CVS Health

Institutional investors have recently bought and sold shares of the business. MidAtlantic Capital Management Inc. bought a new position in CVS Health during the third quarter valued at $25,000. Livelsberger Financial Advisory bought a new position in CVS Health during the third quarter valued at $31,000. Legacy Investment Solutions LLC purchased a new position in shares of CVS Health during the 3rd quarter worth about $31,000. Reston Wealth Management LLC purchased a new position in shares of CVS Health during the 3rd quarter worth about $32,000. Finally, First Community Trust NA boosted its stake in shares of CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after purchasing an additional 302 shares during the period. Institutional investors own 80.66% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.